A potential role of the GRO-α/CXCR2 system in Sjögren's syndrome: Regulatory effects of pro-inflammatory cytokines

Sabrina Lisi, Margherita Sisto, Dario Domenico Lofrumento, Massimo D'Amore, Raffaella De Lucro, Domenico Ribatti

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Chemokines, small pro-inflammatory cytokines, are involved in migration of inflammatory cells in inflamed tissues and recent studies established their role in angiogenesis, hematopoiesis, cancer and autoimmune conditions. Growth related oncogene-alpha (GRO-α), a member of the CXC chemokine family, and its receptor CXCR2 are involved in the inflammatory processes. Since there is no previous report that supports a possible role of GRO-α/CXCR2 receptor complex during inflammation and neovascularization existing in the autoimmune disease Sjögren's syndrome (SS), in this study, we examined CXCR2 and its ligand GRO-α expression in SS tissues. Immunohistochemistry revealed that GRO-α and its receptor CXCR2 were expressed at high levels in diseased tissues compared to healthy controls. In addition, human salivary gland epithelial cells (SGEC) cultures were submitted to a pro-inflammatory microenvironment using cytokines IL-6 and TNF-α in order to demonstrate that CXCR2 may change its initial expression pattern to another under inflammatory condition. The data show an increased expression of CXCR2 depending on the inflammatory cytokine used in culture in a time-dependent manner. Furthermore, silencing of the pro-angiogenic chemokine GRO-α is proportionally correlated with decreased expression of CXCR2 in pro-inflammatory cytokine-stimulated SGEC indicating the GRO-α/CXCR2 complex as a novel therapeutic target for the chronic inflammatory disease Sjögren's syndrome.

Original languageEnglish
Pages (from-to)371-379
Number of pages9
JournalHistochemistry and Cell Biology
Volume139
Issue number2
DOIs
Publication statusPublished - Feb 2013

Fingerprint

Oncogenes
Interleukin-8B Receptors
Cytokines
Growth
Salivary Glands
Chemokines
Epithelial Cells
CXC Chemokines
Hematopoiesis
Autoimmune Diseases
Cell Movement
Interleukin-6
Chronic Disease
Cell Culture Techniques
Immunohistochemistry
Ligands
Inflammation
Neoplasms

Keywords

  • CXCR2
  • GRO-α
  • Salivary gland
  • Sjögren's syndrome

ASJC Scopus subject areas

  • Cell Biology
  • Histology
  • Medical Laboratory Technology
  • Molecular Biology
  • Medicine(all)

Cite this

A potential role of the GRO-α/CXCR2 system in Sjögren's syndrome : Regulatory effects of pro-inflammatory cytokines. / Lisi, Sabrina; Sisto, Margherita; Lofrumento, Dario Domenico; D'Amore, Massimo; De Lucro, Raffaella; Ribatti, Domenico.

In: Histochemistry and Cell Biology, Vol. 139, No. 2, 02.2013, p. 371-379.

Research output: Contribution to journalArticle

Lisi, Sabrina ; Sisto, Margherita ; Lofrumento, Dario Domenico ; D'Amore, Massimo ; De Lucro, Raffaella ; Ribatti, Domenico. / A potential role of the GRO-α/CXCR2 system in Sjögren's syndrome : Regulatory effects of pro-inflammatory cytokines. In: Histochemistry and Cell Biology. 2013 ; Vol. 139, No. 2. pp. 371-379.
@article{b16ca93e3b0f45fa8b393085fb1f88d9,
title = "A potential role of the GRO-α/CXCR2 system in Sj{\"o}gren's syndrome: Regulatory effects of pro-inflammatory cytokines",
abstract = "Chemokines, small pro-inflammatory cytokines, are involved in migration of inflammatory cells in inflamed tissues and recent studies established their role in angiogenesis, hematopoiesis, cancer and autoimmune conditions. Growth related oncogene-alpha (GRO-α), a member of the CXC chemokine family, and its receptor CXCR2 are involved in the inflammatory processes. Since there is no previous report that supports a possible role of GRO-α/CXCR2 receptor complex during inflammation and neovascularization existing in the autoimmune disease Sj{\"o}gren's syndrome (SS), in this study, we examined CXCR2 and its ligand GRO-α expression in SS tissues. Immunohistochemistry revealed that GRO-α and its receptor CXCR2 were expressed at high levels in diseased tissues compared to healthy controls. In addition, human salivary gland epithelial cells (SGEC) cultures were submitted to a pro-inflammatory microenvironment using cytokines IL-6 and TNF-α in order to demonstrate that CXCR2 may change its initial expression pattern to another under inflammatory condition. The data show an increased expression of CXCR2 depending on the inflammatory cytokine used in culture in a time-dependent manner. Furthermore, silencing of the pro-angiogenic chemokine GRO-α is proportionally correlated with decreased expression of CXCR2 in pro-inflammatory cytokine-stimulated SGEC indicating the GRO-α/CXCR2 complex as a novel therapeutic target for the chronic inflammatory disease Sj{\"o}gren's syndrome.",
keywords = "CXCR2, GRO-α, Salivary gland, Sj{\"o}gren's syndrome",
author = "Sabrina Lisi and Margherita Sisto and Lofrumento, {Dario Domenico} and Massimo D'Amore and {De Lucro}, Raffaella and Domenico Ribatti",
year = "2013",
month = "2",
doi = "10.1007/s00418-012-1035-z",
language = "English",
volume = "139",
pages = "371--379",
journal = "Histochemistry and Cell Biology",
issn = "0948-6143",
publisher = "Springer Verlag",
number = "2",

}

TY - JOUR

T1 - A potential role of the GRO-α/CXCR2 system in Sjögren's syndrome

T2 - Regulatory effects of pro-inflammatory cytokines

AU - Lisi, Sabrina

AU - Sisto, Margherita

AU - Lofrumento, Dario Domenico

AU - D'Amore, Massimo

AU - De Lucro, Raffaella

AU - Ribatti, Domenico

PY - 2013/2

Y1 - 2013/2

N2 - Chemokines, small pro-inflammatory cytokines, are involved in migration of inflammatory cells in inflamed tissues and recent studies established their role in angiogenesis, hematopoiesis, cancer and autoimmune conditions. Growth related oncogene-alpha (GRO-α), a member of the CXC chemokine family, and its receptor CXCR2 are involved in the inflammatory processes. Since there is no previous report that supports a possible role of GRO-α/CXCR2 receptor complex during inflammation and neovascularization existing in the autoimmune disease Sjögren's syndrome (SS), in this study, we examined CXCR2 and its ligand GRO-α expression in SS tissues. Immunohistochemistry revealed that GRO-α and its receptor CXCR2 were expressed at high levels in diseased tissues compared to healthy controls. In addition, human salivary gland epithelial cells (SGEC) cultures were submitted to a pro-inflammatory microenvironment using cytokines IL-6 and TNF-α in order to demonstrate that CXCR2 may change its initial expression pattern to another under inflammatory condition. The data show an increased expression of CXCR2 depending on the inflammatory cytokine used in culture in a time-dependent manner. Furthermore, silencing of the pro-angiogenic chemokine GRO-α is proportionally correlated with decreased expression of CXCR2 in pro-inflammatory cytokine-stimulated SGEC indicating the GRO-α/CXCR2 complex as a novel therapeutic target for the chronic inflammatory disease Sjögren's syndrome.

AB - Chemokines, small pro-inflammatory cytokines, are involved in migration of inflammatory cells in inflamed tissues and recent studies established their role in angiogenesis, hematopoiesis, cancer and autoimmune conditions. Growth related oncogene-alpha (GRO-α), a member of the CXC chemokine family, and its receptor CXCR2 are involved in the inflammatory processes. Since there is no previous report that supports a possible role of GRO-α/CXCR2 receptor complex during inflammation and neovascularization existing in the autoimmune disease Sjögren's syndrome (SS), in this study, we examined CXCR2 and its ligand GRO-α expression in SS tissues. Immunohistochemistry revealed that GRO-α and its receptor CXCR2 were expressed at high levels in diseased tissues compared to healthy controls. In addition, human salivary gland epithelial cells (SGEC) cultures were submitted to a pro-inflammatory microenvironment using cytokines IL-6 and TNF-α in order to demonstrate that CXCR2 may change its initial expression pattern to another under inflammatory condition. The data show an increased expression of CXCR2 depending on the inflammatory cytokine used in culture in a time-dependent manner. Furthermore, silencing of the pro-angiogenic chemokine GRO-α is proportionally correlated with decreased expression of CXCR2 in pro-inflammatory cytokine-stimulated SGEC indicating the GRO-α/CXCR2 complex as a novel therapeutic target for the chronic inflammatory disease Sjögren's syndrome.

KW - CXCR2

KW - GRO-α

KW - Salivary gland

KW - Sjögren's syndrome

UR - http://www.scopus.com/inward/record.url?scp=84877134779&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84877134779&partnerID=8YFLogxK

U2 - 10.1007/s00418-012-1035-z

DO - 10.1007/s00418-012-1035-z

M3 - Article

C2 - 23052840

AN - SCOPUS:84877134779

VL - 139

SP - 371

EP - 379

JO - Histochemistry and Cell Biology

JF - Histochemistry and Cell Biology

SN - 0948-6143

IS - 2

ER -